Blog
Investing guides, market analysis, and financial education.
Pfizer Dividend Analysis: Is PFE Worth Buying for Income?
"Pfizer stock sits near $26 with a 6%+ dividend yield — but is the payout actually safe? With restructuring savings materializing and the Seagen oncology pipeline gaining commercial traction, the bull case is stronger than the depressed stock price implies. Here's our verdict."
Jun 19, 2026Dollar-Cost Averaging vs Lump Sum Investing: Which Wins?
Most investors assume the smart move is to wait — accumulate cash, find the perfect entry point, then deploy everything at once. The data says otherwise. A
Jun 17, 2026
Best Dividend Stocks for Passive Income in 2026
Johnson & Johnson just raised its full-year 2026 outlook after posting Q1 revenue of $24.1 billion — a 6.4% year-over-year increase that beat analyst estim
Jun 15, 2026Uber Dividend Analysis: Is UBER Worth Buying for Income?
Uber does not pay a dividend — and that's actually one of the most important things an income investor needs to understand before buying UBER stock in 2026
Jun 15, 2026
Best Brokerage Accounts for Beginners in 2026
The best brokerage accounts for beginners in 2026 require $0 to open — here's which platform actually wins for new investors.
Jun 14, 2026
What Is a P/E Ratio and Why Does It Matter?
The S&P 500 trades near 27–28x earnings in 2026. Here's what the P/E ratio actually means and how to use it.
Jun 14, 2026Dividend Investing Strategy: Build Passive Income with Stocks
Build passive income in 2026 with dividend stocks. Here's the strategy, top picks, and portfolio framework serious income investors are using right now.
Jun 14, 2026
ETF vs Mutual Fund: Which Is Better for Long-Term Investors?
ETFs beat mutual funds for most long-term US investors in 2026 — here's why the cost and tax efficiency gap has become impossible to ignore.
Jun 14, 2026